Understanding Cross-Country Differences In Health Status And Expenditures
Résumé
Using a general equilibrium heterogeneous agent model featuring health production, we quantifythe relative contribution of price distortions in the health market, TFP and other health risks inexplaining cross-country differences in health expenditure (as a share of GDP) and health status.Estimated parameters reveal a substantial price wedge that explains at most 20% of the differencein health spending (as a share of GDP) and 30% of the difference in health status between Europeand the U.S. We estimate a one percentage point negative impact on the life-time cost-of-living ofAmericans from higher prices due to inefficiencies.
Domaines
Economies et financesOrigine | Fichiers produits par l'(les) auteur(s) |
---|